Tech Company Financing Transactions
Edison Pharmaceuticals Funding Round
Edison Pharmaceuticals secured a $2.8 million Series A investment round on 11/21/2005. Investors included Galileo Pharmaceuticals.
Transaction Overview
Company Name
Announced On
11/21/2005
Transaction Type
Venture Equity
Amount
$2,800,000
Round
Series A
Investors
Galileo Pharmaceuticals (Guy Miller)
Proceeds Purpose
The funding will be used to advance EPI-A0001 into clinical development for the treatment of inherited mitochondrial diseases.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
350 North Bernardo Ave.
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Website
Email Address
Overview
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Guy Miller
Chief Medical Officer
Matthew Klein
VP - Manufacturing
Peter Giannousis
VP - R & D
Kerstin Leuther
Browse more venture capital transactions:
Prev: 11/18/2005: BroadLight venture capital transaction
Next: 11/21/2005: Advanced Biohealing venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs